Celldex Therapeutics | CLDX - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.58B 316M 2026-03
Agenus USD 10.56M 13.04M 2025-12
Amgen USD 1.58B 354M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Celldex Therapeutics USD 11.45M 3.61M 2026-03
Glaxosmithkline GBP 3.56B 650.29M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Northwest Biotherapeutics USD 7.07M 1.06M 2025-09
Pfizer USD 2.92B 1.16B 2026-03
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12